New Frontiers in Steroid-Refractory Acute Graft-vs-Host Disease From ASH 2022
Doris M. Ponce, MD, program director of GVHD at Memorial Sloan Kettering Cancer Center in New York City, shared her insights from the 2022 ASH Annual Meeting and Exposition.